Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166546 | SCV000217348 | likely benign | Hereditary cancer-predisposing syndrome | 2014-11-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001704220 | SCV000514360 | likely benign | not provided | 2020-10-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000460582 | SCV000561567 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 4 | 2025-01-17 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000166546 | SCV000686507 | likely benign | Hereditary cancer-predisposing syndrome | 2016-08-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000417545 | SCV000698119 | likely benign | not specified | 2019-08-29 | criteria provided, single submitter | clinical testing |